These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 16392626)

  • 1. Protecting public health in the age of bioterrorism surveillance: is the price right?
    Schneider H
    J Environ Health; 2005 Dec; 68(5):9-13; quiz 29-30. PubMed ID: 16392626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparedness for an anthrax attack.
    Franz DR
    Mol Aspects Med; 2009 Dec; 30(6):503-10. PubMed ID: 19619577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An ounce of prevention is worth a pound of cure: improving communication to reduce mortality during bioterrorism responses.
    Brandeau ML; Zaric GS; Freiesleben J; Edwards FL; Bravata DM
    Am J Disaster Med; 2008; 3(2):65-78. PubMed ID: 18522248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Responding to a bioterrorist attack: environmental investigation of anthrax in New Jersey.
    Valiante DJ; Schill DP; Bresnitz EA; Burr GA; Mead KR
    Appl Occup Environ Hyg; 2003 Oct; 18(10):780-5. PubMed ID: 12959889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cost-effectiveness of strategies to reduce mortality from an intentional release of aerosolized anthrax spores.
    Braithwaite RS; Fridsma D; Roberts MS
    Med Decis Making; 2006; 26(2):182-93. PubMed ID: 16525172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Responding to a bioterrorism attack-one scenario: part 2.
    Clarke TL; Rotarius T; Liberman A; Cattani J; Nieves K; Sumner J; Palaniappan R
    Health Care Manag (Frederick); 2008; 27(4):298-306. PubMed ID: 19011411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling the logistics of response to anthrax bioterrorism.
    Zaric GS; Bravata DM; Cleophas Holty JE; McDonald KM; Owens DK; Brandeau ML
    Med Decis Making; 2008; 28(3):332-50. PubMed ID: 18349432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of anthrax attacks on the American public.
    Blendon RJ; Benson JM; DesRoches CM; Pollard WE; Parvanta C; Herrmann MJ
    MedGenMed; 2002 Apr; 4(2):1. PubMed ID: 12145561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Responding to a small-scale bioterrorist anthrax attack: cost-effectiveness analysis comparing preattack vaccination with postattack antibiotic treatment and vaccination.
    Schmitt B; Dobrez D; Parada JP; Kyriacou DN; Golub RM; Sharma R; Bennett C
    Arch Intern Med; 2007 Apr; 167(7):655-62. PubMed ID: 17420423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pakistan's experience of a bioterrorism-related anthrax scare.
    Ahmad K; Dil AS; Kazi BM; Us-Saba N; Ansari J; Nomani K
    East Mediterr Health J; 2004; 10(1-2):19-26. PubMed ID: 16201705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Bayesian aerosol release detector: an algorithm for detecting and characterizing outbreaks caused by an atmospheric release of Bacillus anthracis.
    Hogan WR; Cooper GF; Wallstrom GL; Wagner MM; Depinay JM
    Stat Med; 2007 Dec; 26(29):5225-52. PubMed ID: 17948918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Environmental monitoring for biological threat agents using the autonomous pathogen detection system with multiplexed polymerase chain reaction.
    Regan JF; Makarewicz AJ; Hindson BJ; Metz TR; Gutierrez DM; Corzett TH; Hadley DR; Mahnke RC; Henderer BD; Breneman JW; Weisgraber TH; Dzenitis JM
    Anal Chem; 2008 Oct; 80(19):7422-9. PubMed ID: 18763806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhalational anthrax.
    Cuneo BM
    Respir Care Clin N Am; 2004 Mar; 10(1):75-82. PubMed ID: 15062228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Responding to biological incidents--what are the current issues in remediation of the contaminated environment?
    Pottage T; Goode E; Wyke S; Bennett AM
    Environ Int; 2014 Nov; 72():133-9. PubMed ID: 24530001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anthrax as a biological weapon: an old disease that poses a new threat.
    Tasota FJ; Henker RA; Hoffman LA
    Crit Care Nurse; 2002 Oct; 22(5):21-32, 34; quiz 35-6. PubMed ID: 12382615
    [No Abstract]   [Full Text] [Related]  

  • 16. Responding to a bioterrorism attack--one scenario: part 1.
    Clarke TL; Rotarius T; Liberman A; Cattani J; Nieves K; Sumner J; Palaniappan R
    Health Care Manag (Frederick); 2008; 27(3):192-211. PubMed ID: 18695399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fear of bioterrorism and implications for public health preparedness.
    Dworkin MS; Ma X; Golash RG
    Emerg Infect Dis; 2003 Apr; 9(4):503-5. PubMed ID: 12702237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Public health. Is safe mail worth the price?
    Florig HK
    Science; 2002 Feb; 295(5559):1467-8. PubMed ID: 11859178
    [No Abstract]   [Full Text] [Related]  

  • 19. Project BioShield: what it is, why it is needed, and its accomplishments so far.
    Russell PK
    Clin Infect Dis; 2007 Jul; 45 Suppl 1():S68-72. PubMed ID: 17582574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential biological targets of Bacillus anthracis in anti-infective approaches against the threat of bioterrorism.
    Bouzianas DG
    Expert Rev Anti Infect Ther; 2007 Aug; 5(4):665-84. PubMed ID: 17678429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.